Simian Vaccine Evaluation Units (SVEUs) 2013

IDIQ

Description

Provide support to maintain and acquire nonhuman primates, and the scientific and technical expertise necessary to conduct studies in nonhuman primates with the objective of providing information that will lead to the development of a human vaccine that can provide broadly reactive and long-lasting protective immunity against HIV infection.

Overview

Ceiling

$80,426,435

Primary Sponsoring Agency

National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]

Who Can Use

One Agency

Primary NAICS

541712 - Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)

Primary PSC

AN81 - R&D- Medical: Aids Research (Basic Research)

Primary Set Aside

None

Extent Competed

Full And Open Competition

Successor

Simian Vaccine Evaluation Units (SVEUs) 2020

Simian Vaccine Evaluation Units (SVEUs) 2013 awarded by National Institute of Allergy and Infectious Diseases (NIAID) in May 2013 accepts orders through April 2020. The IDIQ has a reported ceiling of $80,426,435, and as of today, $68,532,739 has been obligated through the vehicle with a total reported backlog of $13,383,669. The IDIQ was awarded full & open and has a primary NAICS code of 541712.

Award Hierarchy

Vehicle

Simian Vaccine Evaluation Units (SVEUs) 2013

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

5/1/13

Start Date

4/30/20

Ordering Period End Date

100% Complete

Task Order Obligations and Backlog

$68.5M

Total Obligated

$68.5M

Current Award

$81.9M

Potential Award

84% Funded

$0.0

Funded Backlog

$13.4M

Total Backlog

Vehicle Award Share

Contractors with greatest percentage of obligations for Simian Vaccine Evaluation Units (SVEUs) 2013

Vehicle Award Share

Federal Award Analysis